Improved enantioselective assay for the determination of fluoxetine and norfluoxetine enantiomers in human plasma by liquid chromatography

被引:47
作者
Gatti, G
Bonomi, I
Marchiselli, R
Fattore, C
Spina, E
Scordo, G
Pacifici, R
Perucca, E
机构
[1] Univ Pavia, Dept Internal Med & Therapeut, Clin Pharmacol Unit, I-27100 Pavia, Italy
[2] Univ Messina, Dept Clin & Expt Med & Pharmacol, Pharmacol Sect, Messina, Italy
[3] Ist Super Sanita, Dept Clin Biochem, I-00161 Rome, Italy
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2003年 / 784卷 / 02期
关键词
enantiomer separation; fluoxetine; norfluoxetine;
D O I
10.1016/S1570-0232(02)00820-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple and innovative assay is described which allows the chiral separation of the four enantiomers of fluoxetine and norfluoxetine, with performance characteristics adequate for therapeutic drug monitoring. The assay requires liquid-liquid extraction into acetonitrile/n-hexane/isopropylic alcohol and re-extraction into phosphoric acid for clean-up. The acidic layer is injected onto the HPLC system after filtering. Separation of the analytes is achieved with a Chiralcel ODR column and a mobile phase consisting of potassium hexafluorophosphate/acetonitrile. Detection is made by ultraviolet absorbance at 227 nm. Standard curves are linear for each enantiomer (r(2)greater than or equal to0.992) over the range of 10-1000 ng/ml with a limit of quantification of 10 ng/ml for each enantiomer. Within-day and between-day CV% are less than or equal to10% for each enantiomer. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:375 / 383
页数:9
相关论文
共 37 条
[1]   Determination of fluoxetine and its metabolite norfluoxetine in serum and brain areas using high-performance liquid chromatography with ultraviolet detection [J].
Alvarez, JC ;
Bothua, D ;
Colignon, I ;
Advenier, C ;
Spreux-Varoquaux, O .
JOURNAL OF CHROMATOGRAPHY B, 1998, 707 (1-2) :175-180
[2]   Sensitive and rapid method for the simultaneous quantification of five antidepressants with their respective metabolites in plasma using high-performance liquid chromatography with diode-array detection [J].
Aymard, G ;
Livi, P ;
Pham, YT ;
Diquet, B .
JOURNAL OF CHROMATOGRAPHY B, 1997, 700 (1-2) :183-189
[3]   CLINICAL-PHARMACOLOGY AND PHARMACOKINETICS OF FLUOXETINE - A REVIEW [J].
BERGSTROM, RF ;
LEMBERGER, L ;
FARID, NA ;
WOLEN, RL .
BRITISH JOURNAL OF PSYCHIATRY, 1988, 153 :47-50
[4]  
Binsumait IA, 2001, PHARMAZIE, V56, P311
[5]   Simultaneous determination of plasma levels of fluvoxamine and of the enantiomers of fluoxetine and norfluoxetine by gas chromatography mass spectrometry [J].
Eap, CB ;
Gaillard, N ;
Powell, K ;
Baumann, P .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 682 (02) :265-272
[6]   The stereoselective metabolism of fluoxetine in poor and extensive metabolizers of sparteine [J].
Fjordside, L ;
Jeppesen, U ;
Eap, CB ;
Powell, K ;
Baumann, P ;
Brosen, K .
PHARMACOGENETICS, 1999, 9 (01) :55-60
[7]   COMPARISON OF NORFLUOXETINE ENANTIOMERS AS SEROTONIN UPTAKE INHIBITORS INVIVO [J].
FULLER, RW ;
SNODDY, HD ;
KRUSHINSKI, JH ;
ROBERTSON, DW .
NEUROPHARMACOLOGY, 1992, 31 (10) :997-1000
[8]   Pharmacokinetics of selective serotonin reuptake inhibitors [J].
Hiemke, C ;
Härtter, S .
PHARMACOLOGY & THERAPEUTICS, 2000, 85 (01) :11-28
[9]   Quantification of fluoxetine and norfluoxetine serum levels by reversed-phase high-performance liquid chromatography with ultraviolet detection [J].
Holladay, JW ;
Dewey, MJ ;
Yoo, SD .
JOURNAL OF CHROMATOGRAPHY B, 1997, 704 (1-2) :259-263
[10]   Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine: Sources of variability and preliminary observations on relations with clinical response [J].
Jannuzzi, G ;
Gatti, G ;
Magni, P ;
Spina, E ;
Pacifici, R ;
Zuccaro, P ;
Torta, R ;
Guarneri, L ;
Perucca, E .
THERAPEUTIC DRUG MONITORING, 2002, 24 (05) :616-627